Apparent reactivation of a red cell alloantibody in a healthy individual after G‐CSF administration

1998/10/01 by Norol, Bonin, Charpentier +5
Biochemistry, Genetics and Molecular Biology · Medicine · #Blood disorders and treatments #Hematopoietic Stem Cell Transplantation #Blood groups and transfusion

paper · doi:10.1046/j.1365-2141.1998.00950.x

Abstract

Granulocyte-colony stimulating factor (G-CSF) has been successfully administered to healthy subjects to mobilize peripheral blood stem cells (PBSC) for allogeneic transplantation. Adverse events are moderate. We report the first case of apparent reactivation of an alloantibody to a blood cell antigen (Jk(a)) after G-CSF administration to a healthy subject and its transmission to the PBSC transplant recipient; no concomitant reactivation of other alloantibodies was detected. This case raises questions on the effect of G-CSF on the immune system and its safety in healthy individuals.

Related

• Granulocyte colony‐stimulating factor‐induced Sweet syndrome in a healthy donor
• Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project
• Granulocyte‐colony stimulating factor‐induced proliferation of primary adult T‐cell leukaemia cells
• Leukocyte Colony-Stimulating Factors
• Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias